| Literature DB >> 16608108 |
K V Voronkova, O A Pylaeva, O V Mazal'skaia, I D Lemeshko, A S Petrukhin.
Abstract
Clinical efficacy and safety of reminyl monotherapy has been studied in patients with dementia of Alzheimer's and mixed vascular-degenerative types. The reminyl treatment has been conducted in dosage of 16 mg/kg daily during 6 months in 30 patients (20 female, 10 male) aged from 59 to 86 years. The results of the study revealed high efficacy of reminyl in the treatment of patients with mild and moderate dementia and good tolerability of the medication.Entities:
Mesh：
Substances：
Year: 2006 PMID： 16608108
Source DB: PubMed Journal: Zh Nevrol Psikhiatr Im S S Korsakova ISSN： 1997-7298